Delivery Order SPE2DR25D1103-SPE2DR26FE923
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Methylphenidate ER 27 mg tablets in a quantity of 100 units, with a ceiling value of $1,823.28. This competitively awarded, firm fixed-price delivery order is set to be completed by November 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a $1,346.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg on November 24, 2025, with completion scheduled for November 25, 2025. This order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract ceiling value of $1,801.61. This firm fixed-price delivery order, which is set to conclude on September 30, 2025, represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.68 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) on January 21, 2026, with a completion date of January 22, 2026. This firm fixed-price, non-set-aside contract was performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company, Cencora, Inc., which maintains a significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units. This competitive award, valued at $1,108.74, represents a firm fixed-price delivery order with an ultimate completion date of November 7, 2025. The contract was issued with no set-aside designation, and performance will occur at the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36 mg tablets (100 count) on November 7, 2025, with a ceiling value of $2,593.37 and completion deadline of November 10, 2025. This competitively awarded contract utilizing firm fixed pricing represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,478.27. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract ceiling value of $1,000.46. This non-competitive delivery order utilizes firm fixed pricing and requires completion by November 4, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 27 mg tablets (100-count supply) with a ceiling value of $1,146.20. This firm fixed-price, competitively awarded contract was issued on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE923Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract value of $2,451.98. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a small-value pharmaceutical procurement executed through the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement approach. The place of performance is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant $999.999 billion IDC with DLA Troop Support Medical through December 2031. This prime contract vehicle enables the pharmaceutical distributor to supply a comprehensive range of medications and medical supplies supporting military healthcare programs globally. The methylphenidate order fulfills immediate medical needs for the Defense Health Agency and other federal healthcare systems, demonstrating the operational efficiency of DLA's pharmaceutical supply chain in delivering controlled medications to support military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/20/26 |